News
Last week, Brazil obtained marketing authorization for Tafamidis for ATTR cardiomyopathy (ATTR-CM)
December 22, 2019
The refund approval process will begin now. It is important to note that in the past two months, Brazil has experienced 2 other important events.
Good News
December 14, 2019
A decisive first step was taken this week in the Vyndaqel market access procedure for TTR amyloid cardiomyopathies.
Berlin meeting ATTR amyloidosis
December 1, 2019
The 2nd European meeting for ATTR amyloidosis for doctors and patients was held in Berlin the 2 and 3 of September. Read more about the conclusions and see the presentations.
2nd European meeting for ATTR amyloidosis for doctors and patients
May 3, 2019
The 2nd European meeting for ATTR amyloidosis for doctors and patients will be held in Berlin the 2 and 3 of September. All information are available on attrmeeting.org password: ATTR2019
ATTR-Wild Type and Hereditary (Familial) Amyloidosis Support Group Meeting (United States)
April 8, 2019
The Amyloidosis Support Group (ASG) has been holding this biennial support meeting since 2009. This October 25-27, 2019 we expect 500 patients and caregivers from 44 states and Canada to join us in Chicago, Illinois, (U.S.A). We will have amyloidosis researchers and clinicians ("amyloidologists") along with clinical trial liaisons. Sunday